美国胃肠内镜学会关于内镜黏膜下剥离术治疗早期食管癌与胃癌的指南:方法学与证据回顾
该指南由美国胃肠内镜学会(ASGE)采用GRADE框架制定,针对早期食管鳞癌、食管腺癌及胃腺癌及其癌前病变,比较内镜黏膜下剥离术(ESD)与内镜黏膜切除术(EMR)和/或手术的作用,并给出推荐条款。
要点
- 早期食管鳞癌:>15 mm、高分化、无溃疡者,ASGE建议ESD优于EMR;≤15 mm类似病变可ESD或EMR。
- 早期食管腺癌:>20 mm、高分化、无溃疡者,ASGE建议ESD优于EMR;≤20 mm类似病变可ESD或EMR。
- 胃腺癌:20–30 mm高/中分化无溃疡肠型者,ASGE建议ESD优于EMR;<20 mm类似病变可ESD或EMR。
核心结论
- ASGE采用GRADE框架制定本指南,针对早期食管鳞癌、食管腺癌和胃腺癌及其癌前病变,就ESD与EMR和/或手术的选择给出推荐。
研究设计与样本
- 本文件为美国胃肠内镜学会(ASGE)指南的方法学与证据回顾部分,采用GRADE框架进行证据评价。
主要发现
- 对于早期、高分化、无溃疡且>15 mm的食管鳞癌,ASGE建议ESD优于EMR;对于类似病变≤15 mm者,ASGE建议ESD或EMR均可。
- 对于早期、高分化、无溃疡且>20 mm的食管腺癌,ASGE建议ESD优于EMR;对于类似病变≤20 mm者,ASGE建议ESD或EMR均可。
- 对于早期、高或中分化、无溃疡、20至30 mm的肠型胃腺癌,ASGE建议ESD优于EMR;对于类似病变<20 mm者,ASGE建议ESD或EMR均可。
关键数值与推荐
- 食管鳞癌:>15 mm、高分化、无溃疡者,ASGE建议ESD优于EMR(建议,弱推荐)。
- 食管鳞癌:≤15 mm类似病变,ASGE建议ESD或EMR均可(建议,弱推荐)。
- 食管腺癌:>20 mm、高分化、无溃疡者,ASGE建议ESD优于EMR(建议,弱推荐)。
- 胃腺癌:20至30 mm、高或中分化、无溃疡肠型者,ASGE建议ESD优于EMR(建议,弱推荐)。
- 胃腺癌:≤30 mm者,ASGE建议不采用手术(建议不,弱推荐);低分化者无论大小,ASGE建议手术评估优于内镜方法(建议,弱推荐)。
临床怎么用
- 对于早期食管鳞癌患者,ASGE建议尽可能不采用手术(建议不,弱推荐)。
- 对于胃腺癌病灶≤30 mm者,ASGE建议不采用手术(建议不,弱推荐)。
- 对于低分化胃腺癌病灶,无论大小,ASGE建议手术评估优于内镜方法(建议,弱推荐)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
This document from the American Society for Gastrointestinal Endoscopy (ASGE) provides a full description of the methodology used in the review of the evidence used to inform the final guidance outlined in the accompanying Summary and Recommendations document regarding the role of endoscopic submucosal dissection (ESD) in the management of early esophageal and gastric cancers. This guideline used the Grading of Recommendations, Assessment, Development and Evaluation framework and specifically addresses the role of ESD versus EMR and/or surgery, where applicable, for the management of early esophageal squamous cell carcinoma (ESCC), esophageal adenocarcinoma (EAC), and gastric adenocarcinoma (GAC) and their corresponding precursor lesions. For ESCC, the ASGE suggests ESD over EMR for patients with early-stage, well-differentiated, nonulcerated cancer >15 mm, whereas in patients with similar lesions ≤15 mm, the ASGE suggests either ESD or EMR. The ASGE suggests against surgery for such patients with ESCC, whenever possible. For EAC, the ASGE suggests ESD over EMR for patients with early-stage, well-differentiated, nonulcerated cancer >20 mm, whereas in patients with similar lesions measuring ≤20 mm, the ASGE suggests either ESD or EMR. For GAC, the ASGE suggests ESD over EMR for patients with early-stage, well or moderately differentiated, nonulcerated intestinal type cancer measuring 20 to 30 mm, whereas for patients with similar lesions <20 mm, the ASGE suggests either ESD or EMR. The ASGE suggests against surgery for patients with such lesions measuring ≤30 mm, whereas for lesions that are poorly differentiated, regardless of size, the ASGE suggests surgical evaluation over endosic approaches.
引用
- Al-Haddad MA, Elhanafi SE, Forbes N, et al. American Society for Gastrointestinal Endoscopy guideline on endoscopic submucosal dissection for the management of early esophageal and gastric cancers: methodology and review of evidence. Gastrointest Endosc. 2023. PMID: 37498265. doi:10.1016/j.gie.2023.03.030
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。